KMT2C

Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia

KMT2C

Lysine N-methyltransferase 2C (KMT2C) also known as myeloid/lymphoid or mixed-lineage leukemia protein 3 (MLL3) is an enzyme that in humans is encoded by the KMT2C gene.[4][5]

Quick Facts Available structures, PDB ...
KMT2C
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesKMT2C, HALR, MLL3, lysine methyltransferase 2C, KLEFS2
External IDsOMIM: 606833; MGI: 2444959; HomoloGene: 46480; GeneCards: KMT2C; OMA:KMT2C - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_021230
NM_170606

NM_001081383
NM_177283

RefSeq (protein)

NP_733751

n/a

Location (UCSC)Chr 7: 152.13 – 152.44 Mbn/a
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Function

This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT-hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[5]

Interactions

MLL3 has been shown to interact with NCOA6[6] and RBBP5.[6]

Clinical significance

Mutations of the KMT2C gene cause Kleefstra syndrome-2, a neurodevelopmental disorder first described in 2012.[7]

References

Further reading

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.